HLB Therapeutics Co.,Ltd. 115450.KQ Stock
HLB Therapeutics Co.,Ltd. Price Chart
HLB Therapeutics Co.,Ltd. 115450.KQ Financial and Trading Overview
| HLB Therapeutics Co.,Ltd. stock price | 11850 KRW |
| Previous Close | 5000 KRW |
| Open | 5020 KRW |
| Bid | 5200 KRW x 0 |
| Ask | 5210 KRW x 0 |
| Day's Range | 5000 - 5200 KRW |
| 52 Week Range | 4530 - 7536.23 KRW |
| Volume | 547.39K KRW |
| Avg. Volume | 406.65K KRW |
| Market Cap | 125.85B KRW |
| Beta (5Y Monthly) | 0.26132 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
115450.KQ Valuation Measures
| Enterprise Value | 360.15B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.6550782 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.598 |
| Enterprise Value/EBITDA | -60.159 |
Trading Information
HLB Therapeutics Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.26132 |
| 52-Week Change | -21.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7536.23 KRW |
| 52 Week Low | 4530 KRW |
| 50-Day Moving Average | 5184.8 KRW |
| 200-Day Moving Average | 5732.17 KRW |
115450.KQ Share Statistics
| Avg. Volume (3 month) | 406.65K KRW |
| Avg. Daily Volume (10-Days) | 389.28K KRW |
| Shares Outstanding | 24.2M |
| Float | 26.25M |
| Short Ratio | N/A |
| % Held by Insiders | 10.47% |
| % Held by Institutions | 3.82% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -24.20% |
| Operating Margin (ttm) | -16.41% |
| Gross Margin | 17.06% |
| EBITDA Margin | -12.62% |
Management Effectiveness
| Return on Assets (ttm) | -2.97% |
| Return on Equity (ttm) | -10.52% |
Income Statement
| Revenue (ttm) | 47.4B KRW |
| Revenue Per Share (ttm) | 1502.02 KRW |
| Quarterly Revenue Growth (yoy) | 31.30% |
| Gross Profit (ttm) | 5.01B KRW |
| EBITDA | -5986691584 KRW |
| Net Income Avi to Common (ttm) | -11471462400 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.22B KRW |
| Total Cash Per Share (mrq) | 2373.47 KRW |
| Total Debt (mrq) | 57.79B KRW |
| Total Debt/Equity (mrq) | 41.44 KRW |
| Current Ratio (mrq) | 1.456 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10380170240 KRW |
| Levered Free Cash Flow (ttm) | -22530641920 KRW |
Profile of HLB Therapeutics Co.,Ltd.
| Country | South Korea |
| State | N/A |
| City | Seongnam-si |
| Address | Parkview Tower |
| ZIP | N/A |
| Phone | 82 3 1786 7800 |
| Website | https://www.gtreebnt.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 76 |
HLB Therapeutics Co.,Ltd. develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmologic diseases, such as dry eye syndrome and neurotrophic keratopathy; GBT-101 for treating epidermolysis bullosa dermal disease; and OKN-007 for the treatment of glioblastoma brain cancer. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components such as motors, pumps, and trances. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
Q&A For HLB Therapeutics Co.,Ltd. Stock
What is a current 115450.KQ stock price?
HLB Therapeutics Co.,Ltd. 115450.KQ stock price today per share is 11850 KRW.
How to purchase HLB Therapeutics Co.,Ltd. stock?
You can buy 115450.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HLB Therapeutics Co.,Ltd.?
The stock symbol or ticker of HLB Therapeutics Co.,Ltd. is 115450.KQ.
How many shares does HLB Therapeutics Co.,Ltd. have in circulation?
The max supply of HLB Therapeutics Co.,Ltd. shares is 24.2M.
What is HLB Therapeutics Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
HLB Therapeutics Co.,Ltd. PE Ratio is now.
What was HLB Therapeutics Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
HLB Therapeutics Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
HLB Therapeutics Co.,Ltd. 115450.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Composite Index KQ11 | 848.53 KRW 0.64 USD |
-1.39
|
546.42K KRW 412 USD | 842.84 KRW 0.64 USD | 851.22 KRW 0.64 USD | — - | 546.42K KRW 412 USD |
| Kosdaq MID300 Index KQ300 | 720.6 KRW 0.54 USD |
-1.89
|
70.17K KRW 53 USD | 716.77 KRW 0.54 USD | 724.74 KRW 0.55 USD | — - | 70.17K KRW 53 USD |
| Kosdaq Distribution Index KQ19 | 437.59 KRW 0.33 USD |
-1.58
|
40.21K KRW 30 USD | 435.82 KRW 0.33 USD | 440.19 KRW 0.33 USD | — - | 40.21K KRW 30 USD |
- {{ link.label }} {{link}}